Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 4,926,000 | 4,563,000 | 5,111,000 | 4,658,000 | 4,692,000 |
| Cost of Goods | 1,113,000 | 1,100,000 | 1,282,000 | 1,092,000 | 1,054,000 |
| Gross Profit | 3,813,000 | 3,463,000 | 3,829,000 | 3,566,000 | 3,638,000 |
| Operating Expenses | 2,298,000 | 2,112,000 | 2,294,000 | 2,195,000 | 2,185,000 |
| Operating Income | 1,515,000 | 1,351,000 | 1,535,000 | 1,371,000 | 1,453,000 |
| Interest Expense | 69,000 | 65,000 | 68,000 | 69,000 | 75,000 |
| Other Income | -13,000 | 0 | -28,000 | -16,000 | -10,000 |
| Pre-tax Income | 1,433,000 | 1,286,000 | 1,439,000 | 1,286,000 | 1,368,000 |
| Income Tax | 335,000 | 306,000 | 311,000 | 322,000 | 300,000 |
| Net Income Continuous | 1,098,000 | 980,000 | 1,128,000 | 964,000 | 1,068,000 |
| Net Income | $1,098,000 | $980,000 | $1,128,000 | $964,000 | $1,068,000 |
| EPS Basic Total Ops | 0.69 | 0.61 | 0.70 | 0.60 | 0.67 |
| EPS Basic Continuous Ops | 0.69 | 0.61 | 0.71 | 0.61 | 0.67 |
| EPS Diluted Total Ops | 0.68 | 0.61 | 0.70 | 0.60 | 0.66 |
| EPS Diluted Continuous Ops | 0.68 | 0.61 | 0.71 | 0.60 | 0.66 |
| EBITDA(a) | $1,717,000 | $1,550,000 | $1,735,000 | $1,605,000 | $1,689,000 |